ProMIS Neurosciences Inc. (PMN) stock
PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.21+0.08 (+2.56%)
Close on Nov 19, 2026Market cap $28.79MP/E –Yield –
ProMIS Neurosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ProMIS Neurosciences's free cash flow for the twelve months ending Dec 31, 2022 was -$17.04M. For fiscal 2022 it was -$17.04M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$17.04M | – |
| FY2021 | Dec 31, 2021 | -$9.31M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$4.55M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.05M | – |
See a number that looks wrong?